Share on StockTwits
 

Laboratory Corp. of America Holdings (NYSE:LH) COO James T. Jr. Boyle sold 4,123 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $90.29, for a total transaction of $372,265.67. Following the completion of the transaction, the chief operating officer now directly owns 28,188 shares in the company, valued at approximately $2,545,095. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

LH has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Laboratory Corp. of America Holdings in a research note on Monday. They now have a $94.00 price target on the stock. Separately, analysts at Deutsche Bank upgraded shares of Laboratory Corp. of America Holdings from a “hold” rating to a “buy” rating in a research note on Monday. They now have a $98.00 price target on the stock, up previously from $95.00. Finally, analysts at Maxim Group initiated coverage on shares of Laboratory Corp. of America Holdings in a research note on Wednesday, February 5th. They set a “buy” rating and a $110.00 price target on the stock. Fifteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Laboratory Corp. of America Holdings currently has a consensus rating of “Hold” and an average price target of $99.03.

Laboratory Corp. of America Holdings (NYSE:LH) traded up 0.14% on Friday, hitting $91.94. The stock had a trading volume of 864,176 shares. Laboratory Corp. of America Holdings has a 1-year low of $87.01 and a 1-year high of $108.00. The stock’s 50-day moving average is $90.73 and its 200-day moving average is $96.97. The company has a market cap of $8.118 billion and a P/E ratio of 14.69.

Laboratory Corp. of America Holdings (NYSE:LH) last posted its quarterly earnings results on Friday, February 7th. The company reported $1.61 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.66 by $0.05. The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.46 billion. During the same quarter last year, the company posted $1.63 earnings per share. Laboratory Corp. of America Holdings’s revenue was up 2.3% compared to the same quarter last year. On average, analysts predict that Laboratory Corp. of America Holdings will post $6.67 earnings per share for the current fiscal year.

Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.